Cargando…
HEXIM1 is a critical determinant of the response to tamoxifen
Tamoxifen resistance is a major problem in the treatment of Estrogen Receptor (ER) positive patients. We have previously reported that Hexamethylene bis-acetamide Inducible Protein 1 (HEXIM1) inhibits ERα activity by competing with ERα for binding to cyclin T1, a subunit of Positive Transcription El...
Autores principales: | Ketchart, Wannarasmi, Ogba, Ndiya, Kresak, Adam, Albert, Jeffrey M., Pink, John J., Montano, Monica M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136650/ https://www.ncbi.nlm.nih.gov/pubmed/21423213 http://dx.doi.org/10.1038/onc.2011.76 |
Ejemplares similares
-
Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis
por: Ketchart, Wannarasmi, et al.
Publicado: (2012) -
HEXIM1 modulates vascular endothelial growth factor expression and function in breast epithelial cells and mammary gland
por: Ogba, Ndiya, et al.
Publicado: (2010) -
Non-epigenetic induction of HEXIM1 by DNMT1 inhibitors and functional relevance
por: Sharma, Vikas, et al.
Publicado: (2020) -
Inhibition of Tat activity by the HEXIM1 protein
por: Fraldi, Alessandro, et al.
Publicado: (2005) -
HEXIM1-Tat chimera inhibits HIV-1 replication
por: Leoz, Marie, et al.
Publicado: (2018)